McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar entitled "CRISPR Ownership Disputes: Current Status and Future Prospects" on August 18, 2020 from 10:00 am to 11:15 am (CT). In this presentation, Patent Docs author and MBHB attorney Kevin E. Noonan will consider the following details about the technology and the patent disputes relating to ownership:
• A brief overview of the technology
• The players and what they have invented
• The first interference and the grounds for the PTAB's decision
• The current interference, the status of the parties' claims and motions
• Possible outcomes of the PTAB's consideration of these motions
• The upcoming priority phase of the interference
• Potential outcomes and impact on development and commercialization of CRISPR technology
While there is no fee to participate, attendees must register in advance. Those wishing to register can do so here. CLE credit is pending for the states of California, Illinois, New Jersey, New York, North Carolina, and Virginia.
Would another interesting subject of even more economic impact be on avoiding patent infringement for selling products that were originally created by a patented CRISPER method [which could done be some other company] but which do not use any CRISPER technology in any subsequent reproduction or manufacturing? [Also considering the most recent Fed. Cir. decision on "product by process" claims.]
Posted by: Paul F Morgan | August 02, 2020 at 10:55 AM
Thanks for the suggestion, Paul. Likely a good topic for a webinar on "designing around" and the difficulties of establishing infringement for method of making claims
Posted by: Kevin E Noonan | August 05, 2020 at 09:49 AM